NewEdge Advisors’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
33,659
+8,541
+34% +$368K 0.01% 1299
2025
Q4
$1.01M Buy
25,118
+1,525
+6% +$60.4K ﹤0.01% 1485
2025
Q3
$932K Buy
23,593
+23,538
+42,796% +$869K ﹤0.01% 1431
2025
Q2
$2.04K Buy
+55
New +$1.86K ﹤0.01% 3619

Other funds holding CPAI

NewEdge Advisors's CPAI Position: Q1 2026 in Review

NewEdge Advisors increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 34% in Q1 2026, buying an estimated $368K and bringing the position to 33,659 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #1299.

NewEdge Advisors first reported a position in CPAI in Q2 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold CPAI as of Q1 2026.

  • NewEdge Advisors held 33,659 shares of Counterpoint Quantitative Equity ETF worth $1.41M as of Q1 2026.
  • NewEdge Advisors bought 8,541 Counterpoint Quantitative Equity ETF shares in Q1 2026, an estimated $368K.
  • Counterpoint Quantitative Equity ETF made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1299 holding.
  • NewEdge Advisors first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.